Correlation Between Mesa Laboratories and Nautilus Biotechnology
Can any of the company-specific risk be diversified away by investing in both Mesa Laboratories and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesa Laboratories and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesa Laboratories and Nautilus Biotechnology, you can compare the effects of market volatilities on Mesa Laboratories and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesa Laboratories with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesa Laboratories and Nautilus Biotechnology.
Diversification Opportunities for Mesa Laboratories and Nautilus Biotechnology
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Mesa and Nautilus is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Mesa Laboratories and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Mesa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesa Laboratories are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Mesa Laboratories i.e., Mesa Laboratories and Nautilus Biotechnology go up and down completely randomly.
Pair Corralation between Mesa Laboratories and Nautilus Biotechnology
Given the investment horizon of 90 days Mesa Laboratories is expected to under-perform the Nautilus Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Mesa Laboratories is 1.19 times less risky than Nautilus Biotechnology. The stock trades about -0.08 of its potential returns per unit of risk. The Nautilus Biotechnology is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 174.00 in Nautilus Biotechnology on November 5, 2024 and sell it today you would lose (3.00) from holding Nautilus Biotechnology or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mesa Laboratories vs. Nautilus Biotechnology
Performance |
| Timeline |
| Mesa Laboratories |
| Nautilus Biotechnology |
Mesa Laboratories and Nautilus Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mesa Laboratories and Nautilus Biotechnology
The main advantage of trading using opposite Mesa Laboratories and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesa Laboratories position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.| Mesa Laboratories vs. Novanta | Mesa Laboratories vs. Itron Inc | Mesa Laboratories vs. Fortive Corp | Mesa Laboratories vs. Vishay Precision Group |
| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |